Glucagon Receptor

19 Items

per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. glucagon receptor antagonist

    Glucagon receptor antagonists-1 is a highly potent glucagon receptor antagonist.
  2. Glucagon receptor antagonist

    Glucagon receptor antagonists-2 is a highly potent glucagon receptor antagonist.
  3. Glucagon receptor antagonist

    Glucagon receptor antagonists-3 is a highly potent glucagon receptor antagonist.
  4. GCGR inhibitor

    MK 0893 is glucagon receptor antagonist as antidiabetic agents.
  5. Glucagon-Like Peptide 1 (7-36) Amide is a potent glucose-dependent insulinotropic peptide produced by post-translational processing of proglucagon in intestinal L-cells.
  6. Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It works to raise the concentration of glucose in the bloodstream. Its effect is opposite that of insulin, which lowers the glucose.
  7. glucagon receptor inhibitor

    GRA Ex-25 is an inhibitor of glucagon receptor, with IC50 of 56 and 55 nM for rat and human glucagon receptors, respectively.
  8. glucagon receptor antagonist

    PF-06291874 (Glucagon receptor antagonists-4) is a highly potent and orally active glucagon receptor antagonist. It displays low in vivo clearance in both rats and dogs.
  9. glucagon receptor antagonist

    Adomeglivant is a potent and selective glucagon receptor antagonist that is used in clinical trial for type 2 diabetes mellitus.
  10. glucagon-like peptide 1 receptor antagonist

    GLP-1R Antagonist 1 (compound 5d) is an orally active, CNS penetrant and non-competitive antagonist of glucagon-like peptide 1 receptor (GLP-1R), with an IC50 of 650 nM.
  11. glucagon-like peptide-1 receptor agonist

    Exendin-4 Acetate (Exenatide acetate), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM.
  12. glucagon-like peptide-1 receptor agonist

    Exendin-4 (Exenatide), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM.
  13. glucagon receptor antagonist

    LGD-6972 is a glucagon receptor antagonist.
  14. GLP-1R agonist

    PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor agonist (GLP-1R)
  15. Glucagon receptor agonist

    Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity.
  16. Ecnoglutide (XW003) is a glucagon-like peptide 1 (GLP-1) receptor agonist.
  17. HAEGTFTSD is a 9-residue peptide of human GLP-1 peptide or GLP-1(7-36), amide. GLP-1(7-36), amide is a physiological incretin hormone that stimulates insulin secretionin a glucose-dependant manner
  18. HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.
  19. VPAC2 agonist

    Bay 55-9837 is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 may be a useful therapy for the research of type 2 diabetes.

19 Items

per page
Set Descending Direction